KRT88P and hepatocellular carcinoma: The incidence of HBV reactivation between isolate anti-HBc-positive and HBsAb-positive/anti-HBc-positive patients among the HCC group was not different (11.6% [5/43] vs. 11.9% [5/42]; P = 0.968).